Jacqueline E. Shea
2022
In 2022, Jacqueline E. Shea earned a total compensation of $3.5M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 52% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $336,000 |
---|---|
Option Awards | $1,268,362 |
Salary | $729,758 |
Stock Awards | $1,171,474 |
Other | $13,524 |
Total | $3,519,118 |
Shea received $1.3M in option awards, accounting for 36% of the total pay in 2022.
Shea also received $336K in non-equity incentive plan, $729.8K in salary, $1.2M in stock awards and $13.5K in other compensation.
Rankings
In 2022, Jacqueline E. Shea's compensation ranked 1,018th out of 5,736 executives tracked by ExecPay. In other words, Shea earned more than 82.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,018 | 82nd |
Manufacturing | 480 | 85th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 53 | 89th |
Surgical, Medical, And Dental Instruments And Supplies | 34 | 90th |
Surgical and Medical Instruments and Apparatus | 28 | 89th |
Shea's colleagues
We found three more compensation records of executives who worked with Jacqueline E. Shea at Inovio Pharmaceuticals in 2022.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021